Abstract

The pathophysiology of sickle cell disease (SCD) is driven by chronic inflammation fueled by damage associated molecular patterns (DAMPs). We show that elevated cell-free DNA (cfDNA) in patients with SCD is not just a prognostic biomarker, it also contributes to the pathological inflammation. Within the elevated cfDNA, patients with SCD had a significantly higher ratio of cell-free mitochondrial DNA (cf-mtDNA)/cell-free nuclear DNA compared with healthy controls. Additionally, mitochondrial DNA in patient samples showed significantly disproportionately increased hypomethylation compared with healthy controls, and it was increased further in crises compared with steady-state. Using flow cytometry, structured illumination microscopy, and electron microscopy, we showed that circulating SCD red blood cells abnormally retained their mitochondria and, thus, are likely to be the source of the elevated cf-mtDNA in patients with SCD. Patient plasma containing high levels of cf-mtDNA triggered the formation of neutrophil extracellular traps (NETs) that was substantially reduced by inhibition of TANK-binding kinase 1, implicating activation of the cGAS-STING pathway. cf-mtDNA is an erythrocytic DAMP, highlighting an underappreciated role for mitochondria in sickle pathology. These trials were registered at www.clinicaltrials.gov as #NCT00081523, #NCT03049475, and #NCT00047996.

MeSH

Cells, Hematology, Anemia, Sickle Cell, Mitochondria, Microscopy, Dna, Mitochondrial, Dna

Cited by

• The protein interaction of mitochondrial transcription factors A and B2 is associated with 30-day survival in critical COVID-19. Front Immunol, 2025
• Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease. Br J Haematol, 2022
• Dynamic behavior of cell-free mitochondrial DNA in human saliva. Psychoneuroendocrinology, 2022
• Mitochondrial regulation of erythropoiesis in homeostasis and disease. Br J Haematol, 2024
• Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model. Blood Cells Mol Dis, 2022
• Nicotine dose-dependent epigenomic-wide DNA methylation changes in the mice with long-term electronic cigarette exposure. Am J Cancer Res, 2022
• The ultimate tradeoff: how red cell adaptations to malaria alter the host response during critical illness. Am J Physiol Lung Cell Mol Physiol, 2023
• Are Mitochondria a Potential Target for Treating β-Thalassemia? J Clin Med, 2025
• Trafficking and effect of released DNA on cGAS-STING signaling pathway and cardiovascular disease. Front Immunol, 2023
• Dysfunctional telomeres through mitostress-induced cGAS/STING activation to aggravate immune senescence and viral pneumonia. Aging Cell, 2022
• Mitochondria: Emerging Consequential in Sickle Cell Disease. J Clin Med, 2023
• Advances in hydrogels for capturing and neutralizing inflammatory cytokines. J Tissue Eng, 2025
• Chemical Modulation of Gasdermin-Mediated Pyroptosis and Therapeutic Potential. J Mol Biol, 2022
• Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy. Front Med (Lausanne), 2022
• Decreased MFN2 activates the cGAS-STING pathway in diabetic myocardial ischaemia-reperfusion by triggering the release of mitochondrial DNA. Cell Commun Signal, 2023
• The Role of Epithelial Damage in the Pulmonary Immune Response. Cells, 2021
• The Immune Pathogenesis of Acute-On-Chronic Liver Failure and the Danger Hypothesis. Front Immunol, 2022
• Stratification of ββ Compound Heterozygotes Based on L-Glutamine Administration and RDW: Focusing on Disease Severity. Antioxidants (Basel), 2023
• GSDMD promotes neutrophil extracellular traps via mtDNA-cGAS-STING pathway during lung ischemia/reperfusion. Cell Death Discov, 2023
• Multifaceted roles of cGAS-STING pathway in the lung cancer: from mechanisms to translation. PeerJ, 2024